January 2025 – Published Articles

Vulvar Cancer: Histopathologic Considerations and Nuances to Management.
Burt L, Jarboe E, Gaffney D, Suneja G, DeCesaris C, Bedell S, Brower J.Pract Radiat Oncol. 2025 Jan-Feb;15(1):86-92. doi: 10.1016/j.prro.2024.07.008. Epub 2024 Aug 30.PMID: 39209108 Review.

Ensuring High Quality Treatment Plans with a Plan Quality Review Checklist.
Lin MH, Olsen L, Kavanaugh JA, Jacqmin D, Lobb E, Yoo S, Berry SL, Pichardo JC, Cardenas CE, Roper J, Kirk M, Bennett S, Cheung JP, Solberg TD, Moore KL, Kim M.Pract Radiat Oncol. 2025 Jan-Feb;15(1):e82-e87. doi: 10.1016/j.prro.2024.08.008. Epub 2024 Sep 30.PMID: 39357772

Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.
Bruce JY, Burr A, Kimple RJ, Adam DP, Yu M, Piaskowski SM, Glazer TA, Hill P, Hartig GK, McCulloch TM, Wieland AM, Trask D, Oliver K, Longcor J, Rogus-Pulia N, Cho SY, Bednarz B, Harari PM.EBioMedicine. 2025 Jan;111:105496. doi: 10.1016/j.ebiom.2024.105496. Epub 2024 Dec 12.PMID: 39671752 Free PMC article. Clinical Trial.

Patient Perceptions of Radiation Therapy Prior to Initial Consultation With a Radiation Oncologist.
Novak J, Ladbury C, Abuali T, Tam A, Brower J, Evans B, Sun V, Loscalzo MJ, Amini A.Adv Radiat Oncol. 2024 Nov 13;10(1):101676. doi: 10.1016/j.adro.2024.101676. eCollection 2025 Jan.PMID: 39687473 Free PMC article.

Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.
Gunaratne GS, Gallant JP, Ott KL, Broome PL, Celada S, West JL, Mixdorf JC, Aluicio-Sarduy E, Engle JW, Boros E, Meimetis L, Lang JM, Zhao SG, Hernandez R, Kosoff D, LeBeau AM.bioRxiv [Preprint]. 2025 Jan 13:2025.01.13.632555. doi: 10.1101/2025.01.13.632555.PMID: 39868181 Free PMC article. Preprint.

Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.
Uboha NV, Basree MM, Eickhoff JC, Deming DA, Matkowskyj K, Maloney J, McCarthy D, DeCamp M, LoConte N, Emmerich PB, Kraus S, Patel MA, Kratz JD, Lubner SJ, Hurst N, Bassetti MF.J Surg Oncol. 2025 Jan 5. doi: 10.1002/jso.28070. Online ahead of print.PMID: 39757733